ASX - By Stock
|
IXC |
Re:
Ann: Invex Successfully Concludes Protocol Assistance with EMA
|
|
TheDerivative
|
107 |
32K |
0 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
107
|
32K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Half Yearly Report and Accounts
|
|
TheDerivative
|
4 |
1.7K |
6 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
4
|
1.7K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
0 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
102
|
25K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
0 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
102
|
25K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
102
|
25K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
1 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
102
|
25K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Successfully Concludes Protocol Assistance with EMA
|
|
TheDerivative
|
107 |
32K |
1 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
107
|
32K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Successfully Concludes Protocol Assistance with EMA
|
|
TheDerivative
|
107 |
32K |
2 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
107
|
32K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Latest Status
|
|
TheDerivative
|
31 |
8.9K |
4 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
31
|
8.9K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Successfully Concludes Protocol Assistance with EMA
|
|
TheDerivative
|
107 |
32K |
5 |
07/01/21 |
07/01/21 |
ASX - By Stock
|
107
|
32K
|
5
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Invex Successfully Concludes Protocol Assistance with EMA
|
|
TheDerivative
|
107 |
32K |
6 |
23/12/20 |
23/12/20 |
ASX - By Stock
|
107
|
32K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
3 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
102
|
25K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
6 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
102
|
25K
|
6
|
|
ASX - By Stock
|
IXC |
Re:
IXC Broker Data
|
|
TheDerivative
|
102 |
25K |
0 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
102
|
25K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
0 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
47
|
12K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
3 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
47
|
12K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
2 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
52
|
12K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
4 |
12/12/20 |
12/12/20 |
ASX - By Stock
|
52
|
12K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
3 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
52
|
12K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
1 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
52
|
12K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
1 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
52
|
12K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
2 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
52
|
12K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Ceasing to be a substantial holder
|
|
TheDerivative
|
52 |
12K |
0 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
52
|
12K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Chairman's Address to Shareholders and Presentation
|
|
TheDerivative
|
44 |
8.8K |
0 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
44
|
8.8K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Chairman's Address to Shareholders and Presentation
|
|
TheDerivative
|
44 |
8.8K |
0 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
44
|
8.8K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Chairman's Address to Shareholders and Presentation
|
|
TheDerivative
|
44 |
8.8K |
1 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
44
|
8.8K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Chairman's Address to Shareholders and Presentation
|
|
TheDerivative
|
44 |
8.8K |
0 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
44
|
8.8K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
0 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
47
|
12K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
3 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
47
|
12K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
3 |
06/11/20 |
06/11/20 |
ASX - By Stock
|
47
|
12K
|
3
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Investor Presentation
|
|
TheDerivative
|
47 |
12K |
0 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
47
|
12K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase II Clinical Results and Capital Raising Presentation
|
|
TheDerivative
|
50 |
8.1K |
1 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
50
|
8.1K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase II Clinical Results and Capital Raising Presentation
|
|
TheDerivative
|
50 |
8.1K |
1 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
50
|
8.1K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase II Clinical Results and Capital Raising Presentation
|
|
TheDerivative
|
50 |
8.1K |
1 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
50
|
8.1K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Latest Status
|
|
TheDerivative
|
31 |
8.9K |
1 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
31
|
8.9K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Phase II Clinical Results and Capital Raising Presentation
|
|
TheDerivative
|
50 |
8.1K |
2 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
50
|
8.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Latest Status
|
|
TheDerivative
|
31 |
8.9K |
4 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
31
|
8.9K
|
4
|
|
ASX - By Stock
|
IXC |
Re:
Parkinsons
|
|
TheDerivative
|
5 |
1.0K |
0 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
5
|
1.0K
|
0
|
|
ASX - By Stock
|
IXC Biotech |
Re:
Alexandra Sinclair: Easing the pressure
|
|
TheDerivative
|
3 |
1.1K |
2 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
Latest Status
|
|
TheDerivative
|
31 |
8.9K |
0 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
31
|
8.9K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
TheDerivative
|
506 |
94K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
506
|
94K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
TheDerivative
|
506 |
94K |
1 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
506
|
94K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
TheDerivative
|
506 |
94K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
506
|
94K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
IXC chart
|
|
TheDerivative
|
506 |
94K |
0 |
06/10/20 |
06/10/20 |
ASX - By Stock
|
506
|
94K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Director Appointment/Resignation
|
|
TheDerivative
|
5 |
1.4K |
2 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
IXC |
Re:
My take on things - Invex IXC
|
|
TheDerivative
|
3 |
1.3K |
1 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
My take on things - Invex IXC
|
|
TheDerivative
|
3 |
1.3K |
0 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
TheDerivative
|
144 |
36K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
144
|
36K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
TheDerivative
|
144 |
36K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
144
|
36K
|
0
|
|
ASX - By Stock
|
IXC |
Re:
Ann: Initial FDA and EMA Advice on Presendin Development
|
|
TheDerivative
|
144 |
36K |
0 |
11/09/20 |
11/09/20 |
ASX - By Stock
|
144
|
36K
|
0
|
|